Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism.

Respir Med Case Rep 2019 25;26:219-222. Epub 2019 Jan 25.

Department of Internal Medicine, Inha University College of Medicine, South Korea.

Leukocytoclastic vasculitis is a disorder characterized by neutrophilic inflammation that is predominantly limited to the superficial cutaneous postcapillary venules. This condition may be idiopathic or may have a defined cause. Rivaroxaban and dabigatran have been widely used as warfarin alternatives, because of their efficacy and safety. In this case report, we describe a case of leukocytoclastic vasculitis induced by both rivaroxaban- and dabigatran-, which developed during the management of pulmonary thromboembolism.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmcr.2019.01.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356047PMC

Still can't find the full text of the article?

We can help you send a request to the authors directly.
January 2019
5 Reads

Publication Analysis

Top Keywords

leukocytoclastic vasculitis
12
pulmonary thromboembolism
8
management pulmonary
8
postcapillary venules
4
venules condition
4
describe case
4
condition idiopathic
4
case leukocytoclastic
4
cutaneous postcapillary
4
limited superficial
4
vasculitis induced
4
superficial cutaneous
4
alternatives efficacy
4
report describe
4
rivaroxaban dabigatran
4
dabigatran warfarin
4
safety case
4
efficacy safety
4
case report
4
induced rivaroxaban-
4

Similar Publications